SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cadus Pharmaceutical Corp. (KDUS)
An SI Board Since February 1998
Posts SubjectMarks Bans Symbol
1833 48 0 KDUS
Emcee:  Dave K Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1308Stupid question for you: Any time frame estimate on when the Phase II results wiTomato-8/16/2004
1307and July..... solvay.comscaram(o)uche-8/16/2004
1306Icahn to start a hedge fund: <i>In Private World of Hedge Funds, a FamousRCMac-8/3/2004
1305Here's the relevant text from p. 22 of the Solvay presentation linked in RicRCMac-7/20/2004
1304I sent an email Sat. to Director Broach at Princeton on Saturday. No response yTomato-7/20/2004
1303>> SLV320 was still scheduled to transition to a phase II trial, as of 29 scaram(o)uche-7/20/2004
1302Maybe KDUS should use the cash to start a private school dedicated to educating Tomato-7/15/2004
1301last I talked to Ms. Paige, there was potential conflict of interest..... shescaram(o)uche-7/15/2004
1300Doesn't anyone on the Board have a clue? I see board member James R. BroaTomato-7/15/2004
1299It would be fun to be there, just in case clueless Carl shows up. The ops missescaram(o)uche-7/15/2004
1298If anyone DOES attend, can someone tell the new CEO that Solvay says that a Caduscaram(o)uche-7/15/2004
1297Anyone attending the annual meeting next week? eomTomato-7/14/2004
1296bioworld.com Biogen Idec Forms Parkinson's Deal With Vernalis For $100M Bscaram(o)uche-6/30/2004
1295Good news.... SLV320 was still scheduled to transition to a phase II trial, ascaram(o)uche-6/29/2004
1294Biochem Pharmacol. 2004 Jul 15;68(2):305-12. [(3)H]OSIP339391, a selective, nscaram(o)uche-6/15/2004
1293Blast from the past: Message 15978217 I haven't received an annual report yTomato-6/5/2004
1292American Journal of Pathology. 2004;164:1887-1892 Adenosine A2A Receptor Activascaram(o)uche-5/26/2004
1291reuters.co.uk Coffee Drinking May Protect the Liver from Damage Wed 19 May, 200scaram(o)uche-5/19/2004
1290Cadus Announces the Election of David Blitz as Acting Chief 2004-05-13 14:46 (Nemopgcw-5/14/2004
1289Tuck, Did you ever email the SQNM CEO?Tomato-5/13/2004
1288Form 8-K for CADUS CORP ------------------------------------------------------Tomato-5/11/2004
1287I have the feeling that he doesn't want to be the one being bought out. He Tomato-5/8/2004
1286Sometimes I wonder if Carl has any agenda at all with KDUS; if he's more or tuck-5/8/2004
1285Sounds great to me. Would Carl go for it? Seems like he has his own agenda, alTomato-5/8/2004
1284I had an inspired insight the other day . . . Cadus still trades for lesstuck-5/8/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):